tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
VIR is currently covered by 5 analysts with an average price target of $20.8. This is a potential upside of $5.35 (94.21%) from yesterday's end of day stock price of $10.71.
Vir Biotechnology's activity chart (see below) currently has 68 price targets and 82 ratings on display. The stock rating distribution of VIR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 40.45% with an average time for these price targets to be met of 139.48 days.
Highest price target for VIR is $27, Lowest price target is $18, average price target is $20.8.
Most recent stock forecast was given by from MORGAN STANLEY on 11-Jun-2026. First documented stock forecast 05-Nov-2019.
Currently out of the existing stock ratings of VIR, 11 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2026
$27
$16.97 (169.19%)
$24
Buy Since 14-Sep-2022
$21
$10.97 (109.37%)
$20
Buy Since 21-Sep-2020
$20
$9.97 (99.40%)
$15
Buy Since 11-Mar-2021
$18
$7.97 (79.46%)
$14
Buy Since 03-Sep-2025
$18
$7.97 (79.46%)
$12
What is VIR (Vir Biotechnology) average time for price targets to be met?
Which analyst has the current highest performing score on VIR (Vir Biotechnology) with a proven track record?
Which analyst has the most public recommendations on VIR (Vir Biotechnology)?
Which analyst is the currently most bullish on VIR (Vir Biotechnology)?
Which analyst is the currently most reserved on VIR (Vir Biotechnology)?
